Vantis Vascular, Inc. is focused on advancing vascular interventions through innovative technologies designed to enhance the treatment of complex and calcified arteries. Their approach aims to improve the performance, safety, and efficiency of procedures such as percutaneous coronary interventions (PCIs) and below-the-knee (BTK) peripheral interventions. The company recognizes the increasing challenges posed by calcified arteries, which can hinder the delivery of lifesaving therapies. To address these challenges, Vantis Vascular is developing next-generation tools that facilitate superior navigation through difficult anatomical structures, thereby empowering interventionalists to provide more effective treatments.

One of the key technologies being developed by Vantis Vascular is the DuoPRO™ Technology, which allows for seamless navigation through tortuous and calcified arteries. This system features a low-profile, tapered design that enhances the delivery of therapeutic devices, including intravascular lithotripsy (IVL) catheters, to distal lesions. By overcoming the limitations of traditional guide extension systems, Vantis Vascular's innovations aim to streamline the interventional process, reduce the risk of vessel damage, and ultimately improve patient outcomes. The company is committed to creating practice-changing products that will have an immediate impact on interventional procedures, reflecting their dedication to revolutionizing vascular care.

United States

Vantis Vascular is a performance-driven technology company that aims to provide faster, easier, and safer vascular interventions. Their technology is focused on making structural, peripheral, and coronary treatments safer.

Vantis Vascular, Inc.

Company Details